Aitia
PrivateLast Round
Series D
Jul 9, 2019
Total Funding Raised
$48M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aitia operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series D round in July 2019.
Aitia is a biotechnology company that leverages causal AI and its proprietary 'Gemini Digital Twins' platform to simulate human disease biology for drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aitia Comparables
Compare Aitia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Valo Health | 84% | |
| Turbine | 82% | |
| Insilico Medicine | 81% |
For institutional investors. Book with your work email.
Aitia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 9, 2019 | ||||
| VC Round | Aug 23, 2017 | ||||
| Strategic | May 23, 2016 | ||||
| Series C | Dec 8, 2015 | ||||
| Series B | Jan 29, 2014 | ||||
Series A | Apr 18, 2012 |
For institutional investors. Book with your work email.
Aitia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cigna Ventures | Series D |
| GHO Capital | VC Round |
| Amgen Ventures | Series D, VC Round |
| Alexandria Venture Investments | Series D |
| Cigna Investments | Series D |
| Zambon Pharmaceuticals | Series D, VC Round |
| Big Red Ventures | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
Job posting discloses a partnership with Charles River Labs.
- Jul 2, 2026
Job posting discloses a partnership with Orion.
For institutional investors. Book with your work email.
Aitia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aitia's valuation, stock price, and market status.
Is Aitia a public or private company?
Aitia is a private company.
What is the current stock price of Aitia?
Aitia is a private company, so its shares have no public market price. Caplight tracks Aitia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aitia worth (valuation)?
Valuation information for Aitia is not publicly available.
Can I buy Aitia stock?
Aitia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aitia's last funding round?
Aitia's most recent funding round was Series D on July 9, 2019.
Who are the main investors in Aitia?
Key investors in Aitia include Cigna Ventures, Amgen Ventures, Cigna Investments.
Will Aitia IPO soon?
No public IPO plans have been announced for Aitia.
How can I track Aitia secondary market activity?
Caplight tracks bids, offers, and trades in Aitia's shares on secondary markets.